$3.090
-0.326 (-10.56%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Verrica Pharmaceuticals Inc (VRCA) Moving Averages Convergence Divergence (MACD) indicator is -0.28, suggesting VRCA is Strong sell.
Verrica Pharmaceuticals Inc (VRCA) 20-Day simple moving average is 3.50, while Verrica Pharmaceuticals Inc (VRCA) share price is $—, making it Sell.
Verrica Pharmaceuticals Inc (VRCA) 60-Day simple moving average is 4.35, while Verrica Pharmaceuticals Inc (VRCA) share price is $—, making it Sell.
Technical Analysis for VRCA
AI Technical VRCAAs of 2026-11-03, the technical board for Verrica Pharmaceuticals Inc (VRCA) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $3.21 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 37.252, MACD stands at -0.283 (Sell), Stochastic %K stands at 13.044 (Buy), Stochastic %D stands at 12.468 and CCI stands at -115.67 (Buy).
VRCA trades below the 60-day SMA (4.35) and below the 200-day SMA (5.50). Immediate resistance sits at Classic R1 3.65, then R2 3.97. Support sits at Classic S1 3.05, then S2 2.77.
Verrica Pharmaceuticals Inc (VRCA) Support & Resistance Level
Verrica Pharmaceuticals Inc (VRCA) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 37.252 |
| STOCHk_14_3_3 | 13.044 |
| STOCHd_14_3_3 | 12.468 |
| CCI_20 | -115.670 |
| AO_5_34 | -0.596 |
| MOM_10 | -0.320 |
| MACD_12_26_9 | -0.283 |
Verrica Pharmaceuticals Inc (VRCA) Relative Strength Index (RSI_14) is 37.252, creating a Neutral signal.
Verrica Pharmaceuticals Inc (VRCA) Stochastic %K is 13.044, creating a Buy signal.
Verrica Pharmaceuticals Inc (VRCA) Stochastic %D is 12.468, creating a Buy signal.
Verrica Pharmaceuticals Inc (VRCA) CCI_20 is -115.670, creating a Buy signal.
Verrica Pharmaceuticals Inc (VRCA) Awesome Oscillator (AO) is -0.596, creating a Sell signal.
Verrica Pharmaceuticals Inc (VRCA) Momentum (MOM) is -0.320, creating a Sell signal.
Verrica Pharmaceuticals Inc (VRCA) Moving Average Convergence Divergence (MACD) is -0.283, creating a Sell signal.
Verrica Pharmaceuticals Inc (VRCA) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 3.251 | Sell |
| MA_10 | 3.339 | Sell |
| MA_20 | 3.504 | Sell |
| MA_60 | 4.349 | Sell |
| MA_200 | 5.497 | Sell |
| MA_250 | 5.814 | Sell |
Verrica Pharmaceuticals Inc (VRCA) 5-Day simple moving average is 3.251, while Verrica Pharmaceuticals Inc (VRCA) share price is $, making it a Sell.
Verrica Pharmaceuticals Inc (VRCA) 10-Day simple moving average is 3.339, while Verrica Pharmaceuticals Inc (VRCA) share price is $, making it a Sell.
Verrica Pharmaceuticals Inc (VRCA) 20-Day simple moving average is 3.504, while Verrica Pharmaceuticals Inc (VRCA) share price is $, making it a Sell.
Verrica Pharmaceuticals Inc (VRCA) 60-Day simple moving average is 4.349, while Verrica Pharmaceuticals Inc (VRCA) share price is $, making it a Sell.
Verrica Pharmaceuticals Inc (VRCA) 200-Day simple moving average is 5.497, while Verrica Pharmaceuticals Inc (VRCA) share price is $, making it a Sell.
Verrica Pharmaceuticals Inc (VRCA) 250-Day simple moving average is 5.814, while Verrica Pharmaceuticals Inc (VRCA) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.